POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

FDA finds Johnson & Johnson's single-shot COVID-19 vaccine safe

Christian Fernsby |
The US Food and Drug Administration (FDA) says that Johnson & Johnson's single-dose coronavirus vaccine is safe and effective.

Article continues below

A report by the US Food and Drug Administration (FDA) was released ahead of a meeting Friday where experts will discuss the sufficiency of the American drugmaker’s vaccine for emergency use authorization.

The international study, which was conducted in the US, Latin America, and South Africa with 40,000 people, found the company's vaccine to be 66.9% effective in preventing moderate to severe coronavirus symptoms. The efficiency in the US trials was 72%.

"The most common solicited adverse reactions were injection site pain (48.6%), headache (38.9%), fatigue (38.2%)," according to the report.

Johnson & Johnson is also working on a two-dose regimen that might prove more effective.

If the agency authorizes the vaccine, it will be the third shot available in the US after Pfizer-BioNTech and Moderna and become the first global single-shot coronavirus vaccine. All others require two shots at least two weeks apart.

What to read next

Consumers remain highly skeptical of the vaccine
World-first COVID-19 alternating dose vaccine study launches in UK
Congo to deploy controversial Ebola vaccine